PlexBio Co., Ltd. (TPEX:6572)
Taiwan · Delayed Price · Currency is TWD 7.65
-0.04 (-0.52%)
Aug 26, 2026, 1:42 PM CST
PlexBio Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 137.57 | 127.1 | 128.06 | 167.18 | 191.19 | 124.94 |
Revenue Growth | 8.24% | -0.76% | -23.40% | -12.56% | 53.02% | 23.28% |
Gross Profit Gross Profit Growth | 46.69 | 40.41 | 49.26 | 62.47 | 59 | 38.56 |
Operating Income Operating Income Growth | -54.71 | -65.65 | -79.53 | -64.15 | -66.94 | -135.26 |
Net Income Net Income Growth | -38.38 | -62.47 | -61.63 | -58.53 | -53.14 | -131.59 |
Earnings Per Share EPS Growth | -0.37 | -0.60 | -0.59 | -0.56 | -0.51 | -1.27 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Japan Japan Growth | 114.85 | 123.01 | 158.58 | 184.92 | 116.13 |
Taiwan Taiwan Growth | 6.31 | 2.02 | 4.29 | 4.24 | 0.64 |
Europe Europe Growth | 3.75 | - | 2.73 | - | - |
Mainland China Mainland China Growth | 0.3 | 2.74 | 1.41 | 1.93 | 5.69 |
Others Others Growth | 1.88 | 0.28 | 0.17 | 0.11 | 0.91 |
Total Total Growth | 127.1 | 128.06 | 167.18 | 191.19 | 124.94 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 283.2 | 328.44 | 415.53 | 427.87 | 479.36 | 561.78 |
Total Debt Total Debt Growth | 5.23 | 9.56 | 5.67 | 10.85 | 6.02 | 9.15 |
Net Cash (Debt) Net Cash Growth | 277.97 | 318.87 | 409.86 | 417.02 | 473.33 | 552.63 |
Net Cash Growth | -12.83% | -22.20% | -1.72% | -11.90% | -14.35% | -14.29% |
Net Cash Per Share Net Cash Per Share Growth | 2.70 | 3.08 | 3.95 | 4.02 | 4.57 | 5.34 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -47.58 | -79.1 | -5.06 | -29.27 | -71.45 | -84.33 |
Capital Expenditures CapEx Growth | 0.23 | -0.41 | -3.59 | -2.85 | -1.57 | -11.6 |
Free Cash Flow Free Cash Flow Growth | -47.35 | -79.52 | -8.64 | -32.11 | -73.02 | -95.94 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 33.94% | 31.80% | 38.46% | 37.37% | 30.86% | 30.86% |
Operating Margin | -39.77% | -51.65% | -62.10% | -38.38% | -35.01% | -108.26% |
Pretax Margin | -27.90% | -49.15% | -48.13% | -35.01% | -27.79% | -105.32% |
Profit Margin | -27.89% | -49.15% | -48.13% | -35.01% | -27.79% | -105.32% |
FCF Margin | -34.42% | -62.57% | -6.75% | -19.21% | -38.19% | -76.78% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 5.79 | 6.35 | 10.00 | 8.74 | 6.53 | 14.85 |